Allarity Therapeutics, Inc. Accrued Participation Liabilities, Due in Next Operating Cycle
Allarity Therapeutics, Inc. (ALLR) had Accrued Participation Liabilities, Due in Next Operating Cycle of $338.00 thousand as of 2022-09-30, per its 10-Q filed 2023-05-11.
Discontinued › Notes › Other Industries
us-gaap:AccruedParticipationLiabilitiesDueInNextOperatingCycle · last filed 2023-08-14
- 2022-03-31: Accrued Participation Liabilities, Due in Next Operating Cycle 2.27M DKK.
DKK
| Period end | Accrued Participation Liabilities, Due in Next Operating Cycle |
|---|---|
| 2022-03-31 | 2.27M DKK 10-Q · filed 2022-05-27 |
USD
| Period end | Accrued Participation Liabilities, Due in Next Operating Cycle |
|---|---|
| 2022-09-30 | $338.00K 10-Q · filed 2023-05-11 |
| 2022-06-30 | $338.00K 10-Q · filed 2022-10-07 |
| 2022-04-01 | $338.00K 10-Q · filed 2023-08-14 |
| 2022-03-31 | $338.00K 10-Q · filed 2022-05-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |